Stratec SE

Stratec SE

0RAR ·

Stratec SE (0RAR) is a Medical equipment services company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Stratec SE in 2026. The next earnings report is expected on November 12, 2026.

Earnings calendar

Next earnings date

12 Nov 2026

In 82 days

EPS estimate

0.42

Revenue estimate

72.6M

Past earnings

14 Aug 2026
EPS actual
0.39 (+78.9%)
estimate 0.22
Revenue actual
67.5M (+0.5%)
estimate 67.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
11 May 2026
EPS actual
-0.16
estimate 0.00
Revenue actual
61.7M (+2.7%)
estimate 60.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
28 Apr 2026
EPS actual
-0.42 (-151.4%)
estimate 0.82
Revenue actual
88.4M (0.0%)
estimate 88.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
30 Mar 2026
EPS actual
—
estimate 0.82
Revenue actual
—
estimate 88.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
07 Nov 2025
EPS actual
0.15 (-23.5%)
estimate 0.20
Revenue actual
66.9M (-0.2%)
estimate 67.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Stratec SE beat consensus estimates in its latest earnings report, with EPS of USD 0.3883 coming in 78.9% above expectations and revenue of USD 67.5 million exceeding estimates by 0.5%. In the prior quarter EPS missed expectations while revenue came in ahead of estimates by 2.7%.

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Past dividends

Ex-dividend Payment Amount
24 Jun 2026 26 Jun 2026 0.68

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Sector
Healthcare
Industry
Medical equipment services
Country
Germany
Exchange
London Exchange
CEO
Marcus Wolfinger
Employees
1,462
IPO date
10 Sep 2015
ISIN
DE000STRA555
Website
stratec.com

Frequently asked questions

When does Stratec SE (0RAR) next report earnings?

Stratec SE (0RAR) is scheduled to report earnings on November 12, 2026.

What was Stratec SE's most recent earnings date?

Stratec SE (0RAR) last reported earnings on August 14, 2026.

Where is Stratec SE stock listed?

Stratec SE (0RAR) is listed on London Exchange.